Overview

Methadone Effects on Zidovudine (ZDV, AZT) Disposition

Status:
Completed
Trial end date:
1998-10-01
Target enrollment:
Participant gender:
Summary
To determine whether methadone maintenance alters the pharmacokinetics of zidovudine (AZT). To determine whether any such effect of methadone on disposition of AZT is time dependent and whether a metabolic interaction between AZT and methadone exists. Injection drug users represent an increasing proportion of HIV-infected persons. Since daily methadone maintenance is the major chemical treatment for injection drug abuse, it is important to determine the impact of methadone on AZT absorption, distribution, and elimination.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Glaxo Wellcome
Treatments:
Methadone
Zidovudine